3 September 2024: An Extraordinary General Meeting of Aker BioMarine ASA was held today as a digital meeting with online participation.
All proposals on the agenda were adopted, cf. Notice of the Extraordinary General Meeting attached to the stock exchange release dated 12 August 2024.
The complete minutes are attached to this release.
For further information, please contact
Christopher Robin Vinter, VP IR & Corporate Finance
Mobile: +47 911 60 820
Email: Christopher.vinter@akerbiomarine.com
About Aker BioMarine
Aker BioMarine is a leading biotech innovator and Antarctic krill-harvesting company developing krill-derived products for consumer health and wellness as well as animal nutrition. The company has a strong position in its industry and is the world's leading supplier of krill, the natural, powerful and health promoting source of nutrients from the pristine waters of Antarctica. Aker BioMarine is listed on Oslo Stock Exchange (AKBM). More information is available at www.akerbiomarine.com.